FDA Releases Draft Guidance on Bayesian Statistics in Medical Device Clinical Trials

Summary

The Food and Drug Administration (FDA) has released a draft guidance document outlining its recommendations for the use of Bayesian statistics in medical device clinical trials. The document provides guidance on the design and analysis of these trials, and is currently available for public review.